SCHEMBL6601943

SCHEMBL6601943

COc1nn(-c2ccc(NC(=O)c3ccc(S(=O)(=O)F)cc3)cc2)c(=O)o1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.72
LIPC P11150 1/20 0.72
LIPE Q05469 1/20 0.72
ABHD16A O95870 2/20 0.52
FAAH O00519 3/20 0.50
MGLL Q99685 3/20 0.50
ALDH1A1 P00352 4/20 0.46
LMNA P02545 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
POLB P06746 1/20 0.44
MAPT P10636 5/20 0.44
KMT2A Q03164 2/20 0.42
GAA P10253 2/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 2/20 0.42
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047919 0.84 LPL (1.00) LPLLIPCLIPEABHD16AFAAH
SCHEMBL6602780 0.82 LPL (0.74) LPLLIPCLIPEABHD16AFAAH
SCHEMBL6604889 0.81 LPL (0.72) LPLLIPCLIPEABHD16AFAAH
SCHEMBL7044266 0.80 LPL (0.70) LPLLIPCLIPEABHD16AFAAH
SCHEMBL6603718 0.79 LPL (0.69) LPLLIPCLIPEABHD16AFAAH
SCHEMBL7044283 0.78 LPL (0.67) LPLLIPCLIPEABHD16AFAAH
SCHEMBL6600553 0.77 LPL (0.62) LPLLIPCLIPEABHD16AFAAH
SCHEMBL6603513 0.75 LPL (0.64) LPLLIPCLIPEABHD16AFAAH
SCHEMBL6602316 0.74 LPL (0.64) LPLLIPCLIPEABHD16AFAAH
SCHEMBL14679074 0.74 CA1 (0.68) LMNAPOLBMAPTKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263745-B1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE AVENTIS PHARMA GMBH (DE) 2004-05-19 EP disclosed